Clinical Trial

Genetic and Functional Analysis of Aplasia Cutis Congenital (ACC)

Study acronym: ACC
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this research study is to identify genes and regulatory elements on chromosomes that cause ACC. The investigators also study tissue samples from patients to learn about the processes that lead to this disorder.
Protocol Amendment History 13 amendments
This ClinicalTrials.gov record has been amended 13 times since 2012-06-27; most recent amendment 2026-04-14.
Trial Details
NCT Number NCT01630421
Lead Sponsor UConn Health
Conditions Aplasia Cutis Congenita
Enrollment 600 participants
Start Date 2009-04
Primary Completion 2030-12 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-15